Accelerating the development of new therapies and improving the diagnosis and treatment of serious diseases, we deliver value for our investors and partners, as well as those whose lives we touch.
We Deliver at a Global Scale
Benefits for all stakeholders
The combination of Median’s ground-breaking technology and world-class expertise perfectly positions us to revolutionize the field of medical imaging, transforming data generation, management, and access all around the world. Benefiting patients, health professionals, our partners and investors.
Press Releases and Corporate Updates
Latest Press Release
Median Technologies announces 2022 revenue of €23.8 million, up 16%, and an order backlog of €60.8 million
Latest Corporate Update
Corporate Update and Webcast Replay – February 2023
Median Technologies is followed by the analysts listed below.
Any opinions, estimates, forecasts and recommendations regarding Median Technologies made by these analysts are their own. These opinions, estimates, forecasts and recommendations may or may not represent those of Median’s management.
Pierre Alexandre Desir
TP ICAP / Midcap
Bryan, Garnier & Co
Next financial communication: annual results 2022 on April 20, 2023 after trading.